Clinical Trial Update: Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Abraxane (paclitaxel protein-bound particles), bevacizumab, and gemcitabine as first-line therapy for metastatic breast cancer; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Avastin (bevacizumab)
• Gemzar (gemcitabine)

Snippet

Sponsor: University of Miami | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-04-02